Croatia – Pharmaceutical products – Lijekovi rituksimab, emtricitabin+tenofovir, betaksolol, mepolizumab, alprazolam, di
KLINIČKI BOLNIČKI CENTAR RIJEKA awarded a contract of undisclosed value to G-M PHARMA ZAGREB d.o.o. for Healthcare & Medical in June 2024 — one of 805 awards this buyer has made.
Buying agency
KLINIČKI BOLNIČKI CENTAR RIJEKAWinning supplier
G-M PHARMA ZAGREB d.o.o.Contract description
Croatia – Pharmaceutical products – Lijekovi rituksimab, emtricitabin+tenofovir, betaksolol, mepolizumab, alprazolam, dijetetski preparati, oksibuprokain-hidroklorid, palonesteron, etosuksimid - iznimna žurnost
Related awards · KLINIČKI BOLNIČKI CENTAR RIJEKA
805 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-26891-2026-1B.Braun Adria d.o.o.€8.0M15 Jan 2026 Healthcare
- ocds-ted-458689-2026-1SOFMEDICA CROATIA d.o.o.€2.7M03 Jul 2026 Healthcare
- ocds-ted-472597-2026Siemens Healthcare d.o.o.€1.6M09 Jul 2026 Healthcare
Other wins · G-M PHARMA ZAGREB d.o.o.
2 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-339241-2024-8KLINIČKI BOLNIČKI CENTAR RIJEKANot disclosed07 Jun 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for KLINIČKI BOLNIČKI CENTAR RIJEKA and G-M PHARMA ZAGREB d.o.o. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back